🇺🇸 FDA
Patent

US 12268693

Pharmaceutical compositions comprising a tolfenamic acid

granted A61KA61K31/4196A61K31/5415

Quick answer

US patent 12268693 (Pharmaceutical compositions comprising a tolfenamic acid) held by AXSOME THERAPEUTICS, INC. expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/4196, A61K31/5415, A61K47/6951, A61K9/0053